PuSH - Publication Server of Helmholtz Zentrum München

106 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Kunzke, T. et al.: Patterns of carbon-bound exogenous compounds in lung cancer patients and association with disease pathophysiology. Cancer Res., DOI: 10.1158/0008-5472.CAN-21-1175 (2021)
2.
Schoeps, B.* et al.: Timp1 triggers neutrophil extracellular trap formation in pancreatic cancer. Cancer Res. 81, 3568-3579 (2021)
3.
Banga, J.* et al.: Predictive modeling, applied to genetically engineered mouse models of breast or lung cancer, provides insights into major oncogenic pathways. Cancer Res. 80, 35-35 (2020)
4.
Baumeister, S. et al.: Physical activity does not lower the risk of lung cancer. Cancer Res. 80, 3765-3769 (2020)
5.
Liapis, E. ; Klemm, U. ; Karlas, A. ; Reber, J. & Ntziachristos, V.: Resolution of spatial and temporal heterogeneity in bevacizumab-treated breast tumors by eigenspectra multispectral optoacoustic tomography. Cancer Res. 80, 5291-5304 (2020)
7.
Timofeev, O.* et al.: Phosphorylation control of p53 DNA binding cooperativity balances tumorigensis and aging. Cancer Res. 80, 5231-5244 (2020)
8.
Bianco, G.* et al.: HOXA13 drives hepatocytes proliferation and liver tumorigenesis in mice. Cancer Res. 79 (2019)
9.
Ron, A. ; Dean-Ben, X.L. ; Gottschalk, S. & Razansky, D.: Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer. Cancer Res. 79, 4767-4775 (2019)
10.
Shah, R.* ; Singh, S.J.* ; Eddy, K.* ; Filipp, F.V. & Chen, S.*: Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1(+) melanoma. Cancer Res. 79, 1799-1809 (2019)
11.
Lordick, F.* et al.: Heterogeneity of HER2 expression in gastric cancer (GC) leads to high deviation rates between local and central testing and hampers efficacy of anti-HER2 therapy: Survival results from the VARIANZ study. Cancer Res. 78 (2018)
12.
Magkrioti, C.* et al.: The autotaxin - lysophosphatidic acid axis promotes lung carcinogenesis. Cancer Res. 78, 3634-3644 (2018)
13.
Mueller, S.* et al.: Evolutionary trajectories and KRAS gene dosage define pancreatic cancer phenotypes. Cancer Res. 78 (2018)
14.
Mycielska, M.E.* et al.: Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in vivo. Cancer Res. 78, 2513-2523 (2018)
15.
Schirmer, D.* et al.: GPR64-specific CAR-transgenic T cells selectively kill Ewing sarcoma in vivo. Cancer Res. 78 (2018)
16.
Vreka, M. et al.: IkB kinase a Is required for development and progression of KRAS-mutant lung adenocarcinoma. Cancer Res. 78, 2939-2951 (2018)
17.
Wierling, C.* et al.: CanPathPro-development of a platform for predictive pathway modelling using genetically engineered mouse models. Cancer Res. 78 (2018)
18.
Zoni, E.* et al.: Metabolic signature in lethal vs. nonlethal prostate cancer. Cancer Res. 78, 61-62 (2018)
19.
Gires, O.: EGFR-dependent regulated intramembrane proteolysis of EpCAM - Letter. Cancer Res. 77, 1775-1776 (2017)
20.
Koch, M. et al.: Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer. Cancer Res. 77, 623-631 (2017)